Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, Majno PE on behalf of the Metroticket Investigator Study Group, pp.35-43, 2009. ,
Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria ,
HCC: current surgical treatment concepts, Langenbeck's Archives of Surgery, vol.16, issue.Suppl S4, pp.681-695, 2012. ,
DOI : 10.1007/s00423-012-0911-2
Is Resection Equivalent to Transplantation for Early Cirrhotic Patients with Hepatocellular Carcinoma? A Meta-Analysis, Journal of Gastrointestinal Surgery, vol.13, issue.10, pp.16-1897, 2012. ,
DOI : 10.1007/s11605-012-1973-8
Management of early hepatocellular carcinoma in patients with wellcompensated cirrhosis, Ann Surg Oncol, issue.16, pp.1820-1831, 2009. ,
Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma, Journal of Transplantation, vol.100, issue.10, 2010. ,
DOI : 10.1111/j.1600-6143.2009.02984.x
Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list, Liver Transplantation, vol.35, issue.10, pp.873-883, 2002. ,
DOI : 10.1053/jlts.2002.34923
Liver Resection for Hepatocellular Carcinoma ???3 cm: Results of an Italian Multicenter Study on 588 Patients, Journal of the American College of Surgeons, vol.215, issue.2, pp.215-244, 2012. ,
DOI : 10.1016/j.jamcollsurg.2012.04.013
Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma, British Journal of Surgery, vol.143, issue.Suppl 19, pp.98-552, 2011. ,
DOI : 10.1002/bjs.7393
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes, Surgery, vol.141, issue.3, pp.141-330, 2007. ,
DOI : 10.1016/j.surg.2006.06.028
The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets, Seminars in Cancer Biology, vol.21, issue.1, pp.35-43, 2011. ,
DOI : 10.1016/j.semcancer.2010.10.007
Role of the microenvironment in hepatocellular carcinoma development and progression, Cancer Treatment Reviews, vol.38, issue.3, pp.218-243, 2012. ,
DOI : 10.1016/j.ctrv.2011.06.010
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration, Hepatology, vol.196, issue.2, pp.407-414, 1998. ,
DOI : 10.1002/hep.510270214
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection, Journal of Clinical Oncology, vol.25, issue.18, pp.25-2586, 2007. ,
DOI : 10.1200/JCO.2006.09.4565
Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients, Gastroenterology, vol.132, issue.7, pp.132-2328, 2007. ,
DOI : 10.1053/j.gastro.2007.03.102
Jouvin-Marche E, Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis, J Hepatol, issue.1, pp.53-78, 2010. ,
Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma, World Journal of Surgery, vol.17, issue.Suppl 3, pp.32-1757, 2008. ,
DOI : 10.1007/s00268-008-9552-6
Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma, Annals of Surgery, vol.250, issue.1, pp.141-51, 2009. ,
DOI : 10.1097/SLA.0b013e3181a77e59
Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers, Transplantation, vol.91, issue.11, pp.91-1279, 2011. ,
DOI : 10.1097/TP.0b013e3182187cf0
Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma, Pharmacological Research, vol.65, issue.1, pp.23-30, 2012. ,
DOI : 10.1016/j.phrs.2011.11.011
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis, Molecular Cancer, vol.11, issue.1, p.64, 2012. ,
DOI : 10.2741/1933
Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma, International Journal of Clinical Oncology, vol.22, issue.2, pp.18-207, 2013. ,
DOI : 10.1007/s10147-011-0361-9
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study, The Lancet Oncology, vol.14, issue.1, pp.55-63, 2013. ,
DOI : 10.1016/S1470-2045(12)70490-4
A Human Anti-c-Met Fab Fragment Conjugated with Doxorubicin as Targeted Chemotherapy for Hepatocellular Carcinoma, PLoS ONE, vol.122, issue.5, p.63093, 2013. ,
DOI : 10.1371/journal.pone.0063093.t001
Recurrence of Hepatocellular Carcinoma Following Liver Transplantation, Archives of Surgery, vol.143, issue.2, pp.182-188, 2008. ,
DOI : 10.1001/archsurg.2007.39
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients, World Journal of Gastroenterology, vol.12, issue.45, pp.12-7319, 2006. ,
DOI : 10.3748/wjg.v12.i45.7319
URL : https://hal.archives-ouvertes.fr/hal-00483832
Biliary complications after liver transplantation: A review, Scandinavian Journal of Gastroenterology, vol.75, issue.1, pp.89-101, 2006. ,
DOI : 10.1002/hep.1840120523